
Sold some at 17cts, then bought more back at 16cts, seems like easy money. Die die also must hold on till good news break. I missed out on Parkway and Thomson, must not miss out on Healthway. Raffles Med too expensive for me now.
Healthway cannot break above 17half, so came down to square 16. Lucky I not greedy got in 15half and sold 16half for a couple of hundreds dollars gain. Will wait and see. If <15 cents, good to buy some and keep.
DYODD always.
any educated guesses on who the new investors will be ?
it will.
Healthway had well break thr the 200MA. Hope next few days we can see a even much better Healthway.
Cheers.
HEALTHWAY MEDICAL CORPORATION LIMITED
Registration No. 200708625C
CLARIFICATION ON STRAITS TIMES ARTICLE DATED 11 DECEMBER 2010
Healthway Medical Corporation Limited (the “
“Healthway draws investor interest” (the “
provide further clarification in respect of the following statements made in the ST Article:
Company”) refers to The Straits Times articleST Article”) dated 11 December 2010 and would like to1.
400 medical and dental centres as well as specialised hospitals in China in five years
wishes to clarify that this potential scale of operations is achievable against the context of the large
and emerging untapped private healthcare services market in China. However this does not
represent a definitive plan of the Company. The course of action and plans to be adopted by the
Company with respect to its expansion in China in the next five years will be dependent and tailored
to the then prevailing market and business conditions.
The Company notes that the ST Article indicated that the Company “hopes to open 300 to”. The Company2.
increase to more than 50 per cent in five years
expansion plans announced on 14 August 2010 that the China market would form a significant part of
the Company’s future growth plans
In respect of the statement that the proportion of the Group’s revenue from China “may", this is in line with the updates on the Company’s3
Company wishes to clarify that no profit forecast for the next financial year has been made and the
statement was made on the context that the new doctors who joined the Company in 2010 have
started to gain traction in terms of clinical revenue generation and this is expected to improve the
financial performance of the Company and its subsidiaries in the next financial year ending 31
December 2011.
In respect of the statement that "earnings next year should rebound to last year’s levels", the4.
Company wishes to clarify that being a public company listed on Catalist, it occasionally receives and
reviews propositions by interested third parties who express interest to acquire a stake in the
Company. However, such reviews are in their preliminary stages and there is no certainty that these
reviews will proceed beyond the preliminary stages or that any transaction would result from such
reviews. The Company wishes to clarify that, as at the date of this announcement, no memoranda of
understanding or definitive agreements (other than those that have been previously disclosed) have
arisen from any investment propositions. The Company will make the necessary announcements if
there are any material developments in this aspect.
Submitted by Dr Jong Hee Sen, the President and Executive Director of the Company, to the
Singapore Exchange Securities Trading Limited on 13 December 2010.
_________________________________________________________________________________
In respect of the statement that the Company "is speaking to potential investors", theThis announcement has been prepared by the Company and its contents have been reviewed by the
Company’s Sponsor, PrimePartners Corporate Finance Pte. Ltd. (the “
the relevant rules of the Singapore Exchange Securities Trading Limited (“the “
Sponsor has not independently verified the contents of this announcement.
This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes
no responsibility for the contents of this announcement, including the correctness of any of the
statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Mr Mark Liew, Managing Director, Corporate Finance, at 20
Cecil Street, #21-02, Equity Plaza, Singapore 049705, telephone 65-62298088
Sponsor”), for compliance withSGX-ST”). The@ cerebos, he is only in charge of the singapore market only.
epliew ( Date: 13-Dec-2010 11:10) Posted:
|
snooty ( Date: 13-Dec-2010 17:12) Posted:
|
epliew ( Date: 13-Dec-2010 11:30) Posted:
|
how many lots did u invested at 16.5
snooty ( Date: 13-Dec-2010 11:23) Posted:
|
yummygd ( Date: 13-Dec-2010 11:07) Posted:
|